GSK3B and Alzheimer disease: Its phosphorylation leads to the activation of the AKT/GSK-3β pathway and NMDA receptors [72], and both Dab1 expression and phosphorylation are diminished in the cortex and hippocampus of 3xTg-AD mice [73].